-
Study aim
-
Comparison the efficacy of combined treatment of micro needling plus topical bleomycin versus cryotherapy for the treatment of hand and foot refractory warts
-
Design
-
A parallel-group, triple-blind, randomized, phase 3 clinical trial on 90 patients. A sealed envelope was used for randomization.
-
Settings and conduct
-
This study will be conducted in Sina Tabriz Hospital. Blinding was performed for the clinical observer, the analyzer and the outcome assessor.
-
Participants/Inclusion and exclusion criteria
-
Patients with treatment-resistant warts and those who have consented to participate in the study will be included. Pregnant and lactating women, children under four years old, older people over 65 years old, patients under immunosuppressive treatment, patients with immunodeficiency and hypersensitivity reactions, vascular diseases, Raynaud's phenomenon, patients with capillary filling more than two seconds and patients with rheumatological disorders will be excluded from the study.
-
Intervention groups
-
Intervention group 1: Micro-needle is applied to patients once every two weeks. After initial micro-needling, a bleomycin solution of 1 unit/cc is prepared and placed on the site. Micro-needling is used again to deliver bleomycin to the underlying layers, and patients are treated four times at 2-week intervals.
Intervention group 2: For cryotherapy, liquid nitrogen is applied for two cycles of freezing and thawing using a manual spray. The spray gun is kept perpendicular to the wart at a distance of 1 to 2 cm, and the wart is sprayed until the formation of an ice ball spreads from the center to the edge of the wart and a margin of 1 to 2 mm.
-
Main outcome variables
-
Treatment effectiveness from the physician's point of view, treatment effectiveness from the patient's point of view and local pain